Papillary thyroid carcinoma with aggressive fused follicular and solid growth pattern: A unique histological subtype with high-grade malignancy?


Journal

Pathology international
ISSN: 1440-1827
Titre abrégé: Pathol Int
Pays: Australia
ID NLM: 9431380

Informations de publication

Date de publication:
May 2023
Historique:
received: 06 02 2023
accepted: 27 03 2023
medline: 18 5 2023
pubmed: 13 4 2023
entrez: 12 4 2023
Statut: ppublish

Résumé

Papillary thyroid carcinoma (PTC) is usually indolent; however, some rare subtypes of PTCs, such as columnar cell and hobnail subtypes, carry poor prognosis as an intermediate malignancy between differentiated carcinoma and anaplastic carcinoma. We present the case of a 56-year-old Japanese woman having PTC with aggressive behavior showing characteristic histological features of a predominantly fused follicular and focally solid (FFS) pattern. The fused follicular pattern is cribriform-like without intermingled vessels. This PTC with FFS pattern included frequent mitotic figures, necrosis, lymphovascular invasion, and metastases with high clinical stage. The tumor cells were broadly positive for antibodies to TTF-1, PAX8, and bcl-2, and negative for cyclin D1. Ki-67 labeling index was approximately 10%, and there was occasional positivity of p53. Targeted next generation sequencing analysis only detected a NRAS mutation (Q61K); there was no mutation and no translocation of other genes including BRAF and RET/PTC. To our knowledge, this is first report that PTC shows aggressive FFS growth pattern. The tumor is possibly included in the new category of differentiated high-grade thyroid carcinoma in the World Health Organization 2022 classification, or in a novel subtype of PTC owing to its characteristic histological feature and intermediate malignancy between differentiated carcinoma and anaplastic carcinoma.

Identifiants

pubmed: 37042564
doi: 10.1111/pin.13323
doi:

Substances chimiques

Proto-Oncogene Proteins B-raf EC 2.7.11.1

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

207-211

Informations de copyright

© 2023 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.

Références

Rosai J, Lloyd RV, Osamura RY, Kloppel G. WHO classification of tumours of endocrine organs. 4 ed. Lyon: International Agency for Research on Cancer (IARC); 2017.
Jung CK, Bychkov A, Kakudo K. Update from the 2022 World Health Organization classification of thyroid tumors: a standardized diagnostic approach. Endocrinol Metab. 2022;37:703-18.
Nath MC, Erickson LA. Aggressive variants of papillary thyroid carcinoma: hobnail, tall cell, columnar, and solid. Adv Anat Pathol. 2018;25:172-9.
Pizzimenti C, Fiorentino V, Ieni A, Martini M, Tuccari G, Lentini M, et al. Aggressive variants of follicular cell-derived thyroid carcinoma: an overview. Endocrine. 2022;78:1-12.
Wong KS, Dong F, Telatar M, Lorch JH, Alexander EK, Marqusee E, et al. Papillary thyroid carcinoma with high-grade features versus poorly differentiated thyroid carcinoma: an analysis of clinicopathologic and molecular features and outcome. Thyroid. 2021;31:933-40.
Evans HL. Columnar-cell carcinoma of the thyroid. A report of two cases of an aggressive variant of thyroid carcinoma. Am J Clin Path. 1986;85:77-80.
Motosugi U, Murata SI, Nagata K, Yasuda M, Shimizu M. Thyroid papillary carcinoma with micropapillary and hobnail growth pattern: a histological variant with intermediate malignancy? Thyroid. 2009;19:535-7.
Saltman B, Singh B, Hedvat CV, Wreesmann VB, Ghossein R. Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progression. Surgery. 2006;140:899-906.
Lewinski A, Adamczewski Z, Zygmunt A, Markuszewski L, Karbownik-Lewinska M, Stasiak M. Correlations between molecular landscape and sonographic image of different variants of papillary thyroid carcinoma. J Clin Med. 2019;8:1916.

Auteurs

Shin-Ichi Murata (SI)

Department of Human Pathology, Wakayama Medical University, Wakayama, Japan.

Ibu Matsuzaki (I)

Department of Human Pathology, Wakayama Medical University, Wakayama, Japan.

Mitsuo Kishimoto (M)

Department of Surgical Pathology, Kyoto City Hospital, Kyoto, Japan.

Naomi Katsuki (N)

Department of Surgical Pathology, Kyoto City Hospital, Kyoto, Japan.

Toshinori Onishi (T)

Department of Otorhinolaryngology, Kyoto City Hospital, Kyoto, Japan.

Mitsuyoshi Hirokawa (M)

Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Japan.

Fumiyoshi Kojima (F)

Department of Human Pathology, Wakayama Medical University, Wakayama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH